Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Bugs4Urate - Precision Nutrition Strategies for Investigating Probiotic, Diet, Glycan, and Microbiome Factors in Hyperuricemia and Gout Prevention

Project description

Gout prevention nutrition

Gout, a growing lifestyle-related disease in Europe, significantly reduces quality of life, and treatments are often ineffective. Managing hyperuricemia, the precursor to gout, could dramatically improve health outcomes. The EIC-funded Bugs4Urate project aims to address this issue by developing a new probiotic food ingredient with urate-lowering properties, targeting the gut microbiome within a precision nutrition framework. This framework will consider contextual factors including habitual diet, host gut microbiome and host genetics. The project will use machine learning, refine dietary fibre and probiotics and conduct two human intervention studies. Through comprehensive longitudinal analyses, Bugs4Urate seeks to develop an effective tool for identifying responders and non-responders, ultimately aiming to reduce serum urate levels, control inflammation, and prevent gout.

Objective

Gout is a prevalent lifestyle related NCD on the rise in Europe causing low quality of life, yet with inefficient means for treatment. An effective approach to manage hyperuricemia, the precursor to gout, would significantly enhance health outcomes and have a profound impact.

Using a novel probiotic food-ingredient with urate-lowering properties we target the gut microbiome to eradicate urate in a precision nutrition framework where contextualizing factors of the habitual diet, host gut microbiome, and host genetics is used to establish a responder / non-responder instrument.

We will employ a diverse array of methods, encompassing machine learning applied to existing clinical and omics observational data, ex-vivo dietary fiber and probiotic refinement, and two human intervention studies. In healthy adults (n = 8) we will conduct a mode-of-action study utilizing a crossover design including small intestine biopsy sampling to assess local activity. In hyperuricemic participants (n = 99) we will conduct a three-armed, placebo-controlled proof-of-concept study to access the efficacy of probiotic treatment (with and without fibre), combined with a responder / non-responder instrument.

Using comprehensive longitudinal analyses in metabolomics, microbiome, transcriptomics, and glycomics, we aim to uncover the molecular dynamics between dietary patterns, established bacterial enzymatic processes, urate breakdown, and the resultant shifts in inflammation within the gut and throughout the circulatory system. By innovating the glycomics technology to accommodate alternative bio-specimens, we hope to enable straightforward home sampling and initiate early diagnostic procedures for broad population oversight. Through the application of multi-omics, we aim to develop an effective responder / non-responder instrument to probiotic intervention for serum urate reduction, inflammation control, and gout prevention.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2023-PATHFINDERCHALLENGES-01

See all projects funded under this call

Coordinator

KOBENHAVNS UNIVERSITET
Net EU contribution
€ 1 324 692,50
Address
NORREGADE 10
1165 KOBENHAVN
Denmark
Region
Danmark Hovedstaden Byen København
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 324 692,50

Participants (5)